143 related articles for article (PubMed ID: 12434408)
1. Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
Pignatello R; Bucolo C; Puglisi G
J Pharm Sci; 2002 Dec; 91(12):2636-41. PubMed ID: 12434408
[TBL] [Abstract][Full Text] [Related]
2. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Agnihotri SM; Vavia PR
Nanomedicine; 2009 Mar; 5(1):90-5. PubMed ID: 18823824
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.
Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
AAPS PharmSciTech; 2006 Mar; 7(1):E27. PubMed ID: 16584158
[TBL] [Abstract][Full Text] [Related]
4. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
[TBL] [Abstract][Full Text] [Related]
5. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene.
Bucolo C; Maltese A; Maugeri F; Busà B; Puglisi G; Pignatello R
J Pharm Pharmacol; 2004 Jul; 56(7):841-6. PubMed ID: 15233861
[TBL] [Abstract][Full Text] [Related]
6. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene.
Pignatello R; Ricupero N; Bucolo C; Maugeri F; Maltese A; Puglisi G
AAPS PharmSciTech; 2006 Mar; 7(1):E192-E198. PubMed ID: 28290042
[TBL] [Abstract][Full Text] [Related]
8. Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery.
Mandal B; Alexander KS; Riga AT
J Pharm Pharm Sci; 2010; 13(4):510-23. PubMed ID: 21486528
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity.
Katzer T; Chaves P; Bernardi A; Pohlmann A; Guterres SS; Ruver Beck RC
J Microencapsul; 2014; 31(6):519-28. PubMed ID: 24697184
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension.
Bucolo C; Maltese A; Puglisi G; Pignatello R
Ophthalmic Res; 2002; 34(5):319-23. PubMed ID: 12381895
[TBL] [Abstract][Full Text] [Related]
11. Eudragit-based transdermal delivery system of pentazocine: Physico-chemical, in vitro and in vivo evaluations.
Chandak AR; Prasad Verma PR
Pharm Dev Technol; 2010 Jun; 15(3):296-304. PubMed ID: 22716470
[TBL] [Abstract][Full Text] [Related]
12. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
Pignatello R; Bucolo C; Spedalieri G; Maltese A; Puglisi G
Biomaterials; 2002 Aug; 23(15):3247-55. PubMed ID: 12102196
[TBL] [Abstract][Full Text] [Related]
13. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B.
Das S; Suresh PK
Nanomedicine; 2011 Apr; 7(2):242-7. PubMed ID: 20692375
[TBL] [Abstract][Full Text] [Related]
14. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
15. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
16. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
Das SK; Das NG
J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
[TBL] [Abstract][Full Text] [Related]
18. [Study on polymethacrylate nanoparticles as delivery system of antisense oligodeoxynucleotides].
Wang WX; Chen HL; Liang WQ
Yao Xue Xue Bao; 2003 Apr; 38(4):298-301. PubMed ID: 12889133
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of pilocarpine loaded Eudragit nanosuspensions for ocular drug delivery.
Khan MS; Vishakante GD; Bathool A
J Biomed Nanotechnol; 2013 Jan; 9(1):124-31. PubMed ID: 23627075
[TBL] [Abstract][Full Text] [Related]
20. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
Verma P; Gupta RN; Jha AK; Pandey R
Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
